Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 28% ± 9% | |
peripheral blood | 15 studies | 28% ± 8% | |
intestine | 8 studies | 25% ± 8% | |
kidney | 7 studies | 28% ± 4% | |
eye | 6 studies | 28% ± 17% | |
uterus | 6 studies | 30% ± 11% | |
brain | 6 studies | 29% ± 11% | |
lymph node | 5 studies | 28% ± 2% | |
liver | 5 studies | 25% ± 9% | |
bone marrow | 4 studies | 25% ± 8% | |
prostate | 4 studies | 25% ± 5% | |
breast | 4 studies | 37% ± 11% | |
pancreas | 3 studies | 48% ± 8% | |
placenta | 3 studies | 43% ± 6% | |
ovary | 3 studies | 23% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 5139.45 | 328 / 328 | 100% | 104.33 | 178 / 178 |
skin | 100% | 11824.65 | 1809 / 1809 | 100% | 264.98 | 472 / 472 |
esophagus | 100% | 6004.84 | 1444 / 1445 | 100% | 141.46 | 183 / 183 |
brain | 100% | 6909.22 | 2638 / 2642 | 100% | 192.30 | 705 / 705 |
uterus | 100% | 9258.54 | 170 / 170 | 100% | 164.85 | 458 / 459 |
kidney | 100% | 11819.53 | 89 / 89 | 100% | 119.81 | 897 / 901 |
ovary | 100% | 7451.91 | 180 / 180 | 100% | 82.98 | 428 / 430 |
thymus | 100% | 9970.20 | 653 / 653 | 100% | 125.99 | 602 / 605 |
prostate | 100% | 8503.05 | 245 / 245 | 99% | 101.82 | 498 / 502 |
breast | 100% | 9841.24 | 459 / 459 | 99% | 136.59 | 1109 / 1118 |
bladder | 100% | 6714.29 | 21 / 21 | 99% | 138.79 | 498 / 504 |
intestine | 100% | 5145.03 | 966 / 966 | 99% | 118.46 | 520 / 527 |
lung | 100% | 10449.17 | 578 / 578 | 99% | 153.59 | 1139 / 1155 |
stomach | 100% | 5722.06 | 359 / 359 | 99% | 100.97 | 282 / 286 |
adrenal gland | 100% | 8290.60 | 258 / 258 | 96% | 85.17 | 221 / 230 |
liver | 78% | 3119.99 | 176 / 226 | 91% | 62.25 | 368 / 406 |
adipose | 100% | 8201.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 591.09 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 86.62 | 29 / 29 |
spleen | 100% | 6486.97 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 145.89 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 76.98 | 1 / 1 |
blood vessel | 100% | 6813.91 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 96% | 6161.80 | 772 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 7770.59 | 890 / 929 | 0% | 0 | 0 / 0 |
heart | 86% | 2576.73 | 739 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015821 | Biological process | methionine transport |
GO_0015823 | Biological process | phenylalanine transport |
GO_0070327 | Biological process | thyroid hormone transport |
GO_0043330 | Biological process | response to exogenous dsRNA |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0015820 | Biological process | L-leucine transport |
GO_0015818 | Biological process | isoleucine transport |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_0015829 | Biological process | valine transport |
GO_0015824 | Biological process | proline transport |
GO_0015828 | Biological process | tyrosine transport |
GO_0006865 | Biological process | amino acid transport |
GO_1902024 | Biological process | L-histidine transport |
GO_1903801 | Biological process | L-leucine import across plasma membrane |
GO_1904273 | Biological process | L-alanine import across plasma membrane |
GO_0006816 | Biological process | calcium ion transport |
GO_0015827 | Biological process | tryptophan transport |
GO_0035725 | Biological process | sodium ion transmembrane transport |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0044225 | Cellular component | apical pole of neuron |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0009925 | Cellular component | basal plasma membrane |
GO_1990184 | Cellular component | amino acid transport complex |
GO_0009986 | Cellular component | cell surface |
GO_0045202 | Cellular component | synapse |
GO_0070161 | Cellular component | anchoring junction |
GO_0042470 | Cellular component | melanosome |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0015180 | Molecular function | L-alanine transmembrane transporter activity |
GO_0045296 | Molecular function | cadherin binding |
GO_0140272 | Molecular function | exogenous protein binding |
GO_0005294 | Molecular function | neutral L-amino acid secondary active transmembrane transporter activity |
GO_0001618 | Molecular function | virus receptor activity |
GO_0015175 | Molecular function | neutral L-amino acid transmembrane transporter activity |
GO_0015173 | Molecular function | aromatic amino acid transmembrane transporter activity |
GO_0003723 | Molecular function | RNA binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005432 | Molecular function | calcium:sodium antiporter activity |
GO_0005515 | Molecular function | protein binding |
GO_0003725 | Molecular function | double-stranded RNA binding |
GO_0015190 | Molecular function | L-leucine transmembrane transporter activity |
Gene name | SLC3A2 |
Protein name | 4F2 cell-surface antigen heavy chain Solute carrier family 3 member 2 Amino acid transporter heavy chain SLC3A2 (4F2 cell-surface antigen heavy chain) (4F2hc) (4F2 heavy chain antigen) (Lymphocyte activation antigen 4F2 large subunit) (Solute carrier family 3 member 2) (CD antigen CD98) |
Synonyms | MDU1 |
Description | FUNCTION: Acts as a chaperone that facilitates biogenesis and trafficking of functional transporters heterodimers to the plasma membrane. Forms heterodimer with SLC7 family transporters (SLC7A5, SLC7A6, SLC7A7, SLC7A8, SLC7A10 and SLC7A11), a group of amino-acid antiporters . Heterodimers function as amino acids exchangers, the specificity of the substrate depending on the SLC7A subunit. Heterodimers SLC3A2/SLC7A6 or SLC3A2/SLC7A7 mediate the uptake of dibasic amino acids . Heterodimer SLC3A2/SLC7A11 functions as an antiporter by mediating the exchange of extracellular anionic L-cystine and intracellular L-glutamate across the cellular plasma membrane . SLC3A2/SLC7A10 translocates small neutral L- and D-amino acids across the plasma membrane (By similarity). SLC3A2/SLC75 or SLC3A2/SLC7A8 translocates neutral amino acids with broad specificity, thyroid hormones and L-DOPA . SLC3A2 is essential for plasma membrane localization, stability, and the transport activity of SLC7A5 and SLC7A8 . When associated with LAPTM4B, the heterodimer SLC7A5 is recruited to lysosomes to promote leucine uptake into these organelles, and thereby mediates mTORC1 activation . Modulates integrin-related signaling and is essential for integrin-dependent cell spreading, migration and tumor progression . .; FUNCTION: (Microbial infection) In case of hepatitis C virus/HCV infection, the complex formed by SLC3A2 and SLC7A5/LAT1 plays a role in HCV propagation by facilitating viral entry into host cell and increasing L-leucine uptake-mediated mTORC1 signaling activation, thereby contributing to HCV-mediated pathogenesis. .; FUNCTION: (Microbial infection) Acts as a receptor for malaria parasite Plasmodium vivax (Thai isolate) in immature red blood cells. . |
Accessions | ENST00000680631.1 [P08195-2] ENST00000681467.1 P08195 ENST00000377890.6 [P08195-1] A0A7P0Z4A0 F5GZS6 F5H0E2 ENST00000338663.12 [P08195-2] ENST00000539507.1 ENST00000538084.2 [P08195-4] F5H867 A0A7P0TAT7 ENST00000680725.1 ENST00000680002.1 ENST00000680297.1 F5GZR9 F5H056 ENST00000680729.1 ENST00000544377.2 [P08195-2] ENST00000681107.1 ENST00000544377 H0YH36 H0YFS2 ENST00000377889.6 [P08195-3] F5GZI0 A0A7P0Z4P5 A0A7P0TAN7 H0YFX4 A0A7P0TAS6 A0A7P0TBF8 ENST00000538084 A0A7P0T853 ENST00000536981.6 ENST00000679908.1 ENST00000377891.6 [P08195-5] ENST00000535296.5 ENST00000541425.6 ENST00000539458.1 A0A7P0T8F1 ENST00000680610.1 ENST00000541372.1 A0A7P0T8U7 A0A7P0T9F7 ENST00000680134.1 ENST00000539891.6 ENST00000681569.1 ENST00000681657.1 [P08195-2] ENST00000681232.1 |